IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma
 
Sponsors and Collaborators

Immatics Biotechnologies GmbH
 
Contact
Alexandra Kirner, PhD
+49 7071 5397400
[email protected]

Carsten Reinhardt, MD
+49 7071 5397100
[email protected]

 
Principal Investigators
Brian Rini, MD
Cleveland Clinic Taussig Cancer Institute


Continue Reading

Tim Eisen, MD
Addenbrooke’s Hospital University of Cambridge, UK

 
ClinicalTrials.gov Identifier
NCT01265901